These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34657353)

  • 1. Vitiligo Treatment Impact score (VITs): development and validation of a vitiligo burden of treatment questionnaire using the ComPaRe Vitiligo e-cohort.
    Shourick J; Seneschal J; Andreu N; Meurant JM; Pane I; Ravaud P; Tran VT; Ezzedine K
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):279-285. PubMed ID: 34657353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument.
    Gupta V; Sreenivas V; Mehta M; Khaitan BK; Ramam M
    Br J Dermatol; 2014 Nov; 171(5):1084-90. PubMed ID: 24805089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions.
    Tran VT; Montori VM; Eton DT; Baruch D; Falissard B; Ravaud P
    BMC Med; 2012 Jul; 10():68. PubMed ID: 22762722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool.
    Salzes C; Abadie S; Seneschal J; Whitton M; Meurant JM; Jouary T; Ballanger F; Boralevi F; Taieb A; Taieb C; Ezzedine K
    J Invest Dermatol; 2016 Jan; 136(1):52-8. PubMed ID: 26763423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo.
    Krishna GS; Ramam M; Mehta M; Sreenivas V; Sharma VK; Khandpur S
    Indian J Dermatol Venereol Leprol; 2013; 79(2):205-10. PubMed ID: 23442459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform.
    Tran VT; Harrington M; Montori VM; Barnes C; Wicks P; Ravaud P
    BMC Med; 2014 Jul; 12():109. PubMed ID: 24989988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Alzheimer's Disease on Caregiver Questionnaire: internal consistency, convergent validity, and test-retest reliability of a new measure for assessing caregiver burden.
    Cole JC; Ito D; Chen YJ; Cheng R; Bolognese J; Li-McLeod J
    Health Qual Life Outcomes; 2014 Sep; 12():114. PubMed ID: 25186634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ).
    Duncan P; Scott LJ; Dawson S; Munas M; Pyne Y; Chaplin K; Gaunt D; Guenette L; Salisbury C
    BMJ Open; 2024 Apr; 14(4):e080096. PubMed ID: 38604632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What do Vitiligo Impact Scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach.
    Gupta V; Sreenivas V; Mehta M; Ramam M
    Br J Dermatol; 2019 Mar; 180(3):580-585. PubMed ID: 30085349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation and validation of a Spanish version of the treatment burden questionnaire in patients with multiple sclerosis.
    Ysrraelit MC; Fiol MP; Peña FV; Vanotti S; Terrasa SA; Tran VT; Montori VM; Correale J
    BMC Neurol; 2019 Aug; 19(1):209. PubMed ID: 31455235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the DLQI questionnaire in assessing the disease burden and principal aspects related to life quality of vitiligo patients.
    Fekete L; Iantovics LB; Fekete GL
    Front Psychol; 2024; 15():1333723. PubMed ID: 38873521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo: Findings From the Global VALIANT Study.
    Bibeau K; Ezzedine K; Harris JE; van Geel N; Grimes P; Parsad D; Tulpule M; Gardner J; Valle Y; Tlhong Matewa G; LaFiura C; Lindley A; Ren H; Hamzavi IH
    JAMA Dermatol; 2023 Oct; 159(10):1124-1128. PubMed ID: 37647073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage.
    Ongenae K; Dierckxsens L; Brochez L; van Geel N; Naeyaert JM
    Dermatology; 2005; 210(4):279-85. PubMed ID: 15942213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Preliminary Psychometrics of the Exercise Therapy Burden Questionnaire for Patients With Chronic Conditions.
    Martin W; Palazzo C; Poiraudeau S
    Arch Phys Med Rehabil; 2017 Nov; 98(11):2188-2195.e6. PubMed ID: 28427927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian Portuguese.
    Boza JC; Kundu RV; Fabbrin A; Horn R; Giongo N; Cestari TF
    An Bras Dermatol; 2015; 90(3):358-62. PubMed ID: 26131866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a quality of life scale for vitiligo.
    Şenol A; Yücelten AD; Ay P
    Dermatology; 2013; 226(2):185-90. PubMed ID: 23735515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness-to-pay and quality of life in patients with vitiligo.
    Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
    Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conceptualization, development and validation of T-QoL
    Basra MKA; Salek MS; Fenech D; Finlay AY
    Br J Dermatol; 2018 Jan; 178(1):161-175. PubMed ID: 28762236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an instrument to assess treatment adherence for each individual drug taken by a patient.
    Sidorkiewicz S; Tran VT; Cousyn C; Perrodeau E; Ravaud P
    BMJ Open; 2016 May; 6(5):e010510. PubMed ID: 27165645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease Awareness and Treatment Preferences in Vitiligo: A Cross-sectional Study in China.
    Zhang X; Naz AF; Jiang L; Fu C; Huang J; Liang Y; Zhu L; Zhang F; Chen J; Lei L; Zeng Q
    Acta Derm Venereol; 2023 Oct; 103():adv11643. PubMed ID: 37787420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.